- Home
- GPCR vs MKTX Comparison
GPCR vs MKTX Comparison
Compare GPCR & MKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | GPCR | MKTX |
|---|---|---|
| Founded | 2016 | 2000 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Investment Bankers/Brokers/Service |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.3B | 6.0B |
| IPO Year | 2023 | 2004 |
Fundamental Metrics
Financial Performance| Metric | GPCR | MKTX |
|---|---|---|
| Price | $63.38 | $189.40 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 9 |
| Target Price | $104.64 | ★ $204.44 |
| AVG Volume (30 Days) | ★ 778.2K | 554.8K |
| Earning Date | 05-29-2026 | 05-11-2026 |
| Dividend Yield | N/A | ★ 1.65% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 6.64 |
| Revenue | N/A | ★ $397,471,000.00 |
| Revenue This Year | N/A | $10.06 |
| Revenue Next Year | N/A | $7.20 |
| P/E Ratio | ★ N/A | $28.52 |
| Revenue Growth | N/A | ★ 7.45 |
| 52 Week Low | $13.24 | $156.17 |
| 52 Week High | $94.90 | $232.84 |
Technical Indicators
Market Signals| Indicator | GPCR | MKTX |
|---|---|---|
| Relative Strength Index (RSI) | 32.83 | 65.85 |
| Support Level | $60.42 | $177.38 |
| Resistance Level | $72.00 | $191.23 |
| Average True Range (ATR) | 3.33 | 4.62 |
| MACD | -1.01 | 1.53 |
| Stochastic Oscillator | 18.38 | 70.14 |
Price Performance
Historical ComparisonAbout GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About MKTX MarketAxess Holdings Inc.
Founded in 2000, MarketAxess is a leading electronic fixed-income trading platform that connects broker/dealers and institutional investors. The company is primarily focused on credit based fixed income securities with its main trading products being US investment-grade and high-yield bonds, Eurobonds, and Emerging Market corporate debt. Recently the company has expanded more aggressively into Treasuries and municipal bonds with the acquisitions of LiquidityEdge and MuniBrokers in 2019 and 2021, respectively. The company also provides pre- and post-trade services with its acquisition of Regulatory Reporting Hub from Deutsche Börse Group in 2020 adding to its product offerings.